These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31815296)

  • 1. Splicing Regulator p54
    Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
    Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
    Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
    J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY; Sewer MB
    Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
    Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
    Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
    Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
    RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
    Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
    J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of bridging integrator 1 (BIN1) as a potential tumor suppressor and prognostic marker in hepatocellular carcinoma.
    Pan K; Liang XT; Zhang HK; Zhao JJ; Wang DD; Li JJ; Lian Q; Chang AE; Li Q; Xia JC
    Mol Med; 2012 May; 18(1):507-18. PubMed ID: 22281836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear scaffold protein p54
    Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
    Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.
    Fugier C; Klein AF; Hammer C; Vassilopoulos S; Ivarsson Y; Toussaint A; Tosch V; Vignaud A; Ferry A; Messaddeq N; Kokunai Y; Tsuburaya R; de la Grange P; Dembele D; Francois V; Precigout G; Boulade-Ladame C; Hummel MC; Lopez de Munain A; Sergeant N; Laquerrière A; Thibault C; Deryckere F; Auboeuf D; Garcia L; Zimmermann P; Udd B; Schoser B; Takahashi MP; Nishino I; Bassez G; Laporte J; Furling D; Charlet-Berguerand N
    Nat Med; 2011 Jun; 17(6):720-5. PubMed ID: 21623381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NONO and tumorigenesis: More than splicing.
    Feng P; Li L; Deng T; Liu Y; Ling N; Qiu S; Zhang L; Peng B; Xiong W; Cao L; Zhang L; Ye M
    J Cell Mol Med; 2020 Apr; 24(8):4368-4376. PubMed ID: 32168434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
    Xie R; Chen X; Cheng L; Huang M; Zhou Q; Zhang J; Chen Y; Peng S; Chen Z; Dong W; Huang J; Lin T
    Mol Ther; 2021 Jan; 29(1):291-307. PubMed ID: 32950106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA.
    Ding H; Liu J; Wang C; Su Y
    Cancer Cell Int; 2020; 20():425. PubMed ID: 32884448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.
    Ge K; DuHadaway J; Du W; Herlyn M; Rodeck U; Prendergast GC
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9689-94. PubMed ID: 10449755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p54
    Yamamoto R; Osawa T; Sasaki Y; Yamamoto S; Anai M; Izumi K; Matsumura Y; Sakai J; Aburatani H; Mizokami A; Kodama T; Tanaka T
    Oncotarget; 2018 Feb; 9(12):10510-10524. PubMed ID: 29535823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.
    Wechsler-Reya R; Sakamuro D; Zhang J; Duhadaway J; Prendergast GC
    J Biol Chem; 1997 Dec; 272(50):31453-8. PubMed ID: 9395479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription.
    Kuwahara S; Ikei A; Taguchi Y; Tabuchi Y; Fujimoto N; Obinata M; Uesugi S; Kurihara Y
    Biol Reprod; 2006 Sep; 75(3):352-9. PubMed ID: 16641145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.
    de Silva HC; Lin MZ; Phillips L; Martin JL; Baxter RC
    Cell Mol Life Sci; 2019 May; 76(10):2015-2030. PubMed ID: 30725116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
    Pellarin I; Dall'Acqua A; Gambelli A; Pellizzari I; D'Andrea S; Sonego M; Lorenzon I; Schiappacassi M; Belletti B; Baldassarre G
    Oncogene; 2020 May; 39(22):4390-4403. PubMed ID: 32332923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.
    Sewer MB; Nguyen VQ; Huang CJ; Tucker PW; Kagawa N; Waterman MR
    Endocrinology; 2002 Apr; 143(4):1280-90. PubMed ID: 11897684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.